Evaluate the potential impact of a PI3K inhibitor on cancer cells.

It could promote cell survival by enhancing AKT activation.

It could have no effect on cancer cell survival.

It could induce apoptosis by preventing AKT activation and BAD inhibition.

It could directly activate BAD, promoting apoptosis.